Doctor Stine Holmen
Oslo University Hospital Rikshospitalet, Oslo (Norway)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
Event: Heart Failure 2024
Topic: Heart Transplantation
Session: Chronic heart failure - treatment 8
